Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kuan-Yin Shen"'
Autor:
Hung-Chun Liao, Kuan-Yin Shen, Chung-Hsiang Yang, Fang-Feng Chiu, Chen-Yi Chiang, Kit Man Chai, Wan-Chun Huang, Hui-Min Ho, Yi-Hua Chen, Min-Syuan Huang, Ching-Len Liao, Hsin-Wei Chen, Ming-Hsi Huang, Shih-Jen Liu
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 1, Pp 101169- (2024)
DNA vaccines for infectious diseases and cancer have been explored for years. To date, only one DNA vaccine (ZyCoV-D) has been authorized for emergency use in India. DNA vaccines are inexpensive and long-term thermostable, however, limited by the low
Externí odkaz:
https://doaj.org/article/2187e81bfaf341bcb83a79cad68ec35c
Autor:
Tsai-Teng Tzeng, Kit Man Chai, Kuan-Yin Shen, Chia-Yi Yu, Shiu-Ju Yang, Wan-Chun Huang, Hung-Chun Liao, Fang-Feng Chiu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-12 (2022)
Abstract A major challenge in the use of DNA vaccines is efficient DNA delivery in vivo. Establishing a safe and efficient electric transfer method is the key to developing rapid DNA vaccines against emerging infectious diseases. To overcome the comp
Externí odkaz:
https://doaj.org/article/7fd244ca7063404a8b9a951aeb84a487
Autor:
Kit Man Chai, Tsai-Teng Tzeng, Kuan-Yin Shen, Hung-Chun Liao, Jhe-Jhih Lin, Mei-Yu Chen, Guann-Yi Yu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 1, p e0011045 (2023)
[This corrects the article DOI: 10.1371/journal.pntd.0009374.].
Externí odkaz:
https://doaj.org/article/3a3e9c210a774c81beb0f2010bc6d3ae
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/57662c453d214a198d180a9535703189
Autor:
Kit Man Chai, Tsai-Teng Tzeng, Kuan-Yin Shen, Hung-Chun Liao, Jhe-Jhih Lin, Mei-Yu Chen, Guann-Yi Yu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 5, p e0009374 (2021)
The development of efficient vaccines against COVID-19 is an emergent need for global public health. The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major target for the COVID-19 vaccine. To quickly respond to t
Externí odkaz:
https://doaj.org/article/ed966694d2fb48dfa78c64314db836a2
Autor:
Hung-Chun Liao, Wan-Ling Wu, Chen-Yi Chiang, Min-Syuan Huang, Kuan-Yin Shen, Yu-Ling Huang, Suh-Chin Wu, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 9, p 4902 (2022)
During the sustained COVID-19 pandemic, global mass vaccination to achieve herd immunity can prevent further viral spread and mutation. A protein subunit vaccine that is safe, effective, stable, has few storage restrictions, and involves a liable man
Externí odkaz:
https://doaj.org/article/3422b1496f084bac912a9a802542424b
Autor:
Min-Han Lin, Kuan-Yin Shen, Bing-Sin Liu, I-Hua Chen, Yuh-Pyng Sher, Guan-Chin Tseng, Shih-Jen Liu, Wang-Chou Sung
Publikováno v:
Vaccine: X, Vol 1, Iss , Pp - (2019)
The tumor necrosis factor receptor associated protein 1 (TRAP1) is a mitochondria chaperon protein that has been previously implicated as a target for cancer therapy due to its expression level is linked to tumor progression. In this study, an immuno
Externí odkaz:
https://doaj.org/article/2370a381490241f6bca9c8221dc4d70f
Autor:
Yuh-Pyng Sher, Kit Man Chai, Wen-Ching Chen, Kuan-Yin Shen, I-Hua Chen, Ming-Hui Lee, Fang-Feng Chiu, Shih-Jen Liu
Publikováno v:
Vaccines, Vol 8, Iss 4, p 620 (2020)
Peptide vaccines are safe, and aim to elicit and expand tumor-specific immunity so as to eradicate tumors. However, achieving strong and long-lasting anti-tumor immunity with peptide vaccines for the antigen-specific treatment of cancer is challengin
Externí odkaz:
https://doaj.org/article/3e0533cbf3fc4e7f96b97b4f51816749
Autor:
Chiung-Yi Huang, Jeremy J W Chen, Kuan-Yin Shen, Li-Sheng Chang, Yi-Chen Yeh, I-Hua Chen, Pele Chong, Shih-Jen Liu, Chih-Hsiang Leng
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40970 (2012)
The E7 oncoprotein of human papillomavirus (HPV) is an ideal target for developing immunotherapeutic strategies against HPV-associated tumors. However, because protein-based immunogens alone are poor elicitors of the cytotoxic T-lymphocyte (CTL) resp
Externí odkaz:
https://doaj.org/article/f577e7b5d858402f807e6a3f6bad7d71
Autor:
Kuan-Yin Shen, 沈冠印
102
Dendritic cells (DCs) can process and present extracellular antigens on MHC class I molecules to activate cytotoxic T lymphocyte (CTL) responses through an important mechanism, antigen cross-presentation. However, toll-like receptor (TLR)-me
Dendritic cells (DCs) can process and present extracellular antigens on MHC class I molecules to activate cytotoxic T lymphocyte (CTL) responses through an important mechanism, antigen cross-presentation. However, toll-like receptor (TLR)-me
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/02005787959422829416